Hung G, Mercurio V, Hsu S, Mathai SC, Shah AA, Mukherjee M. Progress in understanding, diagnosing, and managing cardiac complications of systemic sclerosis. Curr Rheumatol Rep. 2019;21:68.

Article  PubMed  PubMed Central  Google Scholar 

Mathai SC. Pulmonary Hypertension Associated with connective tissue disease. Cardiol Clin. 2022;40:29–43. https://doi.org/10.1016/j.ccl.2021.08.003.

Article  PubMed  Google Scholar 

Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum. 2007;56:2740–6. https://doi.org/10.1002/art.22747.

Article  PubMed  Google Scholar 

Bruni C, Buch MH, Djokovic A, De Luca G, Dumitru RB, Giollo A, Galetti I, Steelandt A, Bratis K, Suliman YA, et al. Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment. J Scleroderma Relat Disord. 2023;8:169–82. https://doi.org/10.1177/23971983231163413.

Article  PubMed  PubMed Central  Google Scholar 

Hsu S, Kokkonen-Simon KM, Kirk JA, Kolb TM, Damico RL, Mathai SC, Mukherjee M, Shah AA, Wigley FM, Margulies KB, et al. Right ventricular myofilament functional differences in humans with systemic sclerosis-Associated Versus Idiopathic Pulmonary arterial hypertension. Circulation. 2018;137:2360–70. https://doi.org/10.1161/circulationaha.117.033147.

Article  PubMed  PubMed Central  Google Scholar 

Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020;8:304–20. https://doi.org/10.1016/S2213-2600(19)30480-1.

Article  CAS  PubMed  Google Scholar 

Farrukh L, Steen V, Shapiro L, Faddoul G, Mehta S. Spectrum of renal disease in scleroderma other than scleroderma renal crisis: a review of the literature. Clin Nephrol. 2024;102:97–106. https://doi.org/10.5414/CN111243.

Article  CAS  PubMed  Google Scholar 

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airo P, Joven B, Vettori S, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76:1897–905. https://doi.org/10.1136/annrheumdis-2017-211448.

Article  PubMed  Google Scholar 

Bruni C, Buch MH, Furst DE, De Luca G, Djokovic A, Dumitru RB, Giollo A, Polovina M, Steelandt A, Bratis K, et al. Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition. J Scleroderma Relat Disord. 2022;7:24–32. https://doi.org/10.1177/23971983211053246.

Article  PubMed  Google Scholar 

Fairley JL, Ross L, Quinlivan A, Hansen D, Paratz E, Stevens W, Kistler PM, McLellan A, La Gerche A, Nikpour M. Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2023;62:152229. https://doi.org/10.1016/j.semarthrit.2023.152229.

Article  PubMed  Google Scholar 

Dumitru RB, Bissell LA, Erhayiem B, Fent G, Kidambi A, Swoboda P, Abignano G, Donica H, Burska A, Greenwood JP, et al. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis. Rheumatology (Oxford). 2021;60:2934–45. https://doi.org/10.1093/rheumatology/keaa742.

Article  CAS  PubMed  Google Scholar 

Cavazzana I, Vojinovic T, Airo P, Fredi M, Ceribelli A, Pedretti E, Lazzaroni MG, Garrafa E, Franceschini F. Systemic sclerosis-specific antibodies: Novel and classical biomarkers. Clin Rev Allergy Immunol. 2023;64:412–30. https://doi.org/10.1007/s12016-022-08946-w.

Article  CAS  PubMed  Google Scholar 

Connolly CM, Paik JJ. Myopathy in systemic sclerosis. Curr Opin Rheumatol. 2023;35:341–8. https://doi.org/10.1097/BOR.0000000000000966.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paik JJ, Choi DY, Mukherjee M, Hsu S, Wigley F, Shah AA, Hummers LK. Troponin elevation independently associates with mortality in systemic sclerosis. Clin Exp Rheumatol. 2022;40:1933–40. https://doi.org/10.55563/clinexprheumatol/fytfmy.

Article  PubMed  PubMed Central  Google Scholar 

Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide. Arthritis Care Res (Hoboken). 2015;67:1022–30. https://doi.org/10.1002/acr.22547.

Article  CAS  PubMed  Google Scholar 

Allanore Y, Komocsi A, Vettori S, Hachulla E, Hunzelmann N, Distler J, Avouac J, Gobeaux C, Launay D, Czirjak L, et al. N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis. Int J Cardiol. 2016;223:385–9. https://doi.org/10.1016/j.ijcard.2016.08.246.

Article  PubMed  Google Scholar 

Moore DF, Kramer E, Eltaraboulsi R, Steen VD. Increased morbidity and mortality of Scleroderma in African americans compared to non-african americans. Arthritis Care Res (Hoboken). 2019;71:1154–63. https://doi.org/10.1002/acr.23861.

Article  PubMed  Google Scholar 

Faccini A, Agricola E, Oppizzi M, Margonato A, Galderisi M, Sabbadini MG, Franchini S, Camici PG. Coronary microvascular dysfunction in asymptomatic patients affected by systemic sclerosis - limited vs. diffuse form. Circ J. 2015;79:825–9. https://doi.org/10.1253/circj.CJ-14-1114.

Article  PubMed  Google Scholar 

Allanore Y, Meune C. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin. Clin Exp Rheumatol. 2010;28:S48–53.

CAS  PubMed  Google Scholar 

Gonzalez Garcia A, Fabregate M, Manzano L, Guillen Del Castillo A, Rubio Rivas M, Argibay A, Marin Ballve A, Rodriguez Pinto I, Pla Salas X, Mari-Alfonso B, et al. Left ventricular diastolic dysfunction in systemic sclerosis: clinical, immunological and survival differences in the Spanish RESCLE registry. Semin Arthritis Rheum. 2022;55:152033. https://doi.org/10.1016/j.semarthrit.2022.152033.

Article  PubMed  Google Scholar 

Vos JL, Lemmers JMJ, El Messaoudi S, Snoeren M, van Dijk APJ, Duijnhouwer AL, Rodwell L, van Leuven SI, Post MC, Vonk MC, et al. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension. Eur Heart J Cardiovasc Imaging. 2024;25:708–17. https://doi.org/10.1093/ehjci/jeae001.

Article  PubMed  PubMed Central  Google Scholar 

Weber BN, Paik JJ, Aghayev A, Klein AL, Mavrogeni SI, Yu PB, Mukherjee M. Novel imaging approaches to Cardiac manifestations of systemic inflammatory diseases: JACC Scientific Statement. J Am Coll Cardiol. 2023;82:2128–51. https://doi.org/10.1016/j.jacc.2023.09.819.

Article  PubMed  PubMed Central  Google Scholar 

Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, et al. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022;23:e308–22. https://doi.org/10.1093/ehjci/jeac134.

Article  CAS  PubMed  Google Scholar 

De Luca G, Campochiaro C, De Santis M, Sartorelli S, Peretto G, Sala S, Canestrari G, De Lorenzis E, Basso C, Rizzo S, et al. Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. Rheumatology (Oxford). 2020;59:2523–33. https://doi.org/10.1093/rheumatology/kez658.

Article  CAS  PubMed  Google Scholar 

Treutlein C, Distler JHW, Tascilar K, Fakhouri SC, Gyorfi AH, Atzinger A, Matei AE, Dees C, Buttner-Herold M, Kuwert T, et al. Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT. Eur J Nucl Med Mol Imaging. 2023;50:1629–35. https://doi.org/10.1007/s00259-022-06081-4.

Article  CAS  PubMed  Google Scholar 

Fairley JL, Hansen D, Burns A, Prior D, La Gerche A, Morrisroe K, Stevens W, Nikpour M, Ross LJ. Contribution of left ventricular diastolic dysfunction to survival and breathlessness in systemic sclerosis-Associated interstitial lung disease. J Rheumatol. 2024;51:495–504. https://doi.org/10.3899/jrheum.2023-0801.

Article  PubMed  Google Scholar 

Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, Di Mario C, Forni F, Gremese E, Ferraccioli G. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: a prospective study. Eur J Intern Med. 2018. https://doi.org/10.1016/j.ejim.2018.10.013.

Article  PubMed  Google Scholar